

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.37385216 |
| 2 | negative T cell selection (GO:0043383) | 5.90491606 |
| 3 | negative thymic T cell selection (GO:0045060) | 5.65210385 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.58906856 |
| 5 | positive thymic T cell selection (GO:0045059) | 5.40051702 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14746645 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.14746645 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.14055282 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.03437277 |
| 10 | positive T cell selection (GO:0043368) | 4.99782139 |
| 11 | thymic T cell selection (GO:0045061) | 4.93496535 |
| 12 | response to interleukin-15 (GO:0070672) | 4.74428308 |
| 13 | T cell selection (GO:0045058) | 4.72028025 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71273888 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64832491 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.64832491 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 4.59147251 |
| 18 | interferon-gamma production (GO:0032609) | 4.37737070 |
| 19 | cytidine deamination (GO:0009972) | 4.37238772 |
| 20 | cytidine metabolic process (GO:0046087) | 4.37238772 |
| 21 | cytidine catabolic process (GO:0006216) | 4.37238772 |
| 22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.36038678 |
| 23 | leukocyte aggregation (GO:0070486) | 4.33392816 |
| 24 | T cell receptor signaling pathway (GO:0050852) | 4.27752220 |
| 25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.19209231 |
| 26 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.13274552 |
| 27 | T cell migration (GO:0072678) | 4.13091357 |
| 28 | ribosomal small subunit assembly (GO:0000028) | 4.05643925 |
| 29 | T cell costimulation (GO:0031295) | 4.00796518 |
| 30 | lymphocyte costimulation (GO:0031294) | 3.96605633 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.94506393 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.94023193 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91319072 |
| 34 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.90650526 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86355423 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73672274 |
| 37 | DNA deamination (GO:0045006) | 3.67629856 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.65174287 |
| 39 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.64775337 |
| 40 | viral transcription (GO:0019083) | 3.63401747 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.62967953 |
| 42 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.61475083 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.59631351 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57486600 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.51911237 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.48846644 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.48846644 |
| 48 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.48694802 |
| 49 | response to type I interferon (GO:0034340) | 3.47679578 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.46214636 |
| 51 | translational termination (GO:0006415) | 3.45888949 |
| 52 | V(D)J recombination (GO:0033151) | 3.44404698 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.43075446 |
| 54 | positive regulation of cell killing (GO:0031343) | 3.38464903 |
| 55 | regulation of cell killing (GO:0031341) | 3.38075571 |
| 56 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.36965840 |
| 57 | Peyers patch development (GO:0048541) | 3.36965840 |
| 58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.30989473 |
| 59 | detection of bacterium (GO:0016045) | 3.29418552 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29206102 |
| 61 | positive regulation of interleukin-2 production (GO:0032743) | 3.21887996 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.20289330 |
| 63 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.18303175 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 3.17654100 |
| 65 | T cell homeostasis (GO:0043029) | 3.16222960 |
| 66 | positive regulation of isotype switching (GO:0045830) | 3.13875069 |
| 67 | tolerance induction (GO:0002507) | 3.13752934 |
| 68 | dendritic cell chemotaxis (GO:0002407) | 3.13686377 |
| 69 | negative regulation of T cell apoptotic process (GO:0070233) | 3.13500087 |
| 70 | positive regulation of tolerance induction (GO:0002645) | 3.13099001 |
| 71 | lymphocyte migration (GO:0072676) | 3.12080945 |
| 72 | detection of other organism (GO:0098543) | 3.11522225 |
| 73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11190055 |
| 74 | mast cell activation (GO:0045576) | 3.11042461 |
| 75 | positive regulation of defense response to virus by host (GO:0002230) | 3.09103677 |
| 76 | translational elongation (GO:0006414) | 3.08705583 |
| 77 | positive regulation of interleukin-4 production (GO:0032753) | 3.08476573 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07472995 |
| 79 | regulation of alpha-beta T cell activation (GO:0046634) | 3.07053209 |
| 80 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.05698220 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05640005 |
| 82 | positive regulation of T cell mediated immunity (GO:0002711) | 3.04078372 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.03744374 |
| 84 | B cell mediated immunity (GO:0019724) | 3.02825839 |
| 85 | negative regulation of innate immune response (GO:0045824) | 3.02644035 |
| 86 | regulation of T cell mediated immunity (GO:0002709) | 3.01730576 |
| 87 | T cell differentiation (GO:0030217) | 3.01148984 |
| 88 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.99668601 |
| 89 | sequestering of actin monomers (GO:0042989) | 2.99200114 |
| 90 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.98819079 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98229917 |
| 92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97244509 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.97068919 |
| 94 | maturation of SSU-rRNA (GO:0030490) | 2.96284725 |
| 95 | respiratory burst (GO:0045730) | 2.93993316 |
| 96 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.91531093 |
| 97 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.88886005 |
| 98 | DNA unwinding involved in DNA replication (GO:0006268) | 2.88632958 |
| 99 | regulation of response to interferon-gamma (GO:0060330) | 2.88254075 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88158115 |
| 101 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88158115 |
| 102 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.87607518 |
| 103 | regulation of isotype switching (GO:0045191) | 2.86061194 |
| 104 | activated T cell proliferation (GO:0050798) | 2.84607911 |
| 105 | natural killer cell activation (GO:0030101) | 2.80746481 |
| 106 | cellular response to interleukin-4 (GO:0071353) | 2.79588363 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.77950198 |
| 108 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.77795772 |
| 109 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76788400 |
| 110 | lymphocyte homeostasis (GO:0002260) | 2.76632649 |
| 111 | mast cell degranulation (GO:0043303) | 2.75060242 |
| 112 | mast cell activation involved in immune response (GO:0002279) | 2.75060242 |
| 113 | alpha-beta T cell activation (GO:0046631) | 2.74155860 |
| 114 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.73326724 |
| 115 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.73326724 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72892501 |
| 117 | translational initiation (GO:0006413) | 2.72706223 |
| 118 | T cell activation (GO:0042110) | 2.72148859 |
| 119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.71574635 |
| 120 | regulation of tolerance induction (GO:0002643) | 2.70884703 |
| 121 | somatic cell DNA recombination (GO:0016444) | 2.70432258 |
| 122 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.70432258 |
| 123 | cotranslational protein targeting to membrane (GO:0006613) | 2.70098948 |
| 124 | viral life cycle (GO:0019058) | 2.69864892 |
| 125 | protein targeting to ER (GO:0045047) | 2.69740440 |
| 126 | cellular protein complex disassembly (GO:0043624) | 2.67861506 |
| 127 | positive regulation of granulocyte differentiation (GO:0030854) | 2.66600785 |
| 128 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.66474084 |
| 129 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.66279899 |
| 130 | positive regulation of DNA recombination (GO:0045911) | 2.64258253 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.63195196 |
| 132 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.62069462 |
| 133 | leukocyte cell-cell adhesion (GO:0007159) | 2.61624933 |
| 134 | somatic diversification of immune receptors (GO:0002200) | 2.61551696 |
| 135 | negative regulation of phagocytosis (GO:0050765) | 2.60161041 |
| 136 | alpha-beta T cell differentiation (GO:0046632) | 2.59150911 |
| 137 | DNA strand elongation (GO:0022616) | 2.56117917 |
| 138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56095979 |
| 139 | regulation of B cell mediated immunity (GO:0002712) | 2.56049866 |
| 140 | positive regulation of immunoglobulin production (GO:0002639) | 2.56004874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.80575373 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.18181303 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.63472671 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58691499 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82440239 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82336922 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.77231912 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75386252 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53023153 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51206978 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42817009 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.42227414 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39890362 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36870124 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32618021 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31081874 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28725313 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.27017309 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23063500 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19408741 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18290864 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.15263209 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09939492 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06810820 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96437051 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.95741490 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92615486 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.90321068 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89402457 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89140263 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85375333 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.85245045 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81351514 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.80357331 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76351869 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73446395 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.73396817 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73243093 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69788281 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.68268361 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67279805 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67222198 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66972358 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63771268 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60693197 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59786103 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59054780 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56911899 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55364897 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53639803 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53172714 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52939123 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45600995 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44000272 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.42333559 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41291356 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41133045 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39955879 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.36934709 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33367835 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31980051 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31868812 |
| 63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31557963 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31033052 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28099753 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.27905671 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27419167 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.26260028 |
| 69 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.26198826 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25550248 |
| 71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24989954 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23274365 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.22989196 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22898199 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21458672 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20381686 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20194238 |
| 78 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19719538 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17113593 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15791476 |
| 81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15571501 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15268758 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15114761 |
| 84 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13519578 |
| 85 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.12492923 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10280852 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09956556 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 1.09082337 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08678863 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08301842 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07572180 |
| 92 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07530027 |
| 93 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05085342 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02941789 |
| 95 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02931934 |
| 96 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02584021 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01987939 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01945872 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01602752 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00530546 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00287107 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00115905 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99224339 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99077200 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98857710 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98548190 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98158862 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98118043 |
| 109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97811210 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97024890 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96867628 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96677214 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94679382 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.94430500 |
| 115 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94372035 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94105139 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92764066 |
| 118 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92740088 |
| 119 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92620224 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91127156 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 0.91015251 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90995048 |
| 123 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90604498 |
| 124 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90540112 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90447681 |
| 126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89466560 |
| 127 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89430419 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.88203226 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87670395 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87598902 |
| 131 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87523177 |
| 132 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87464267 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86554994 |
| 134 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86511795 |
| 135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85531951 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85468806 |
| 137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84881440 |
| 138 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83775194 |
| 139 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83772963 |
| 140 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83300039 |
| 141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83124831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.92758542 |
| 2 | MP0005671_abnormal_response_to | 3.94618319 |
| 3 | MP0000685_abnormal_immune_system | 3.45963689 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.31209222 |
| 5 | MP0001800_abnormal_humoral_immune | 3.19707270 |
| 6 | MP0002398_abnormal_bone_marrow | 2.97240833 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.91982811 |
| 8 | MP0005387_immune_system_phenotype | 2.76389301 |
| 9 | MP0001790_abnormal_immune_system | 2.76389301 |
| 10 | MP0000703_abnormal_thymus_morphology | 2.71539230 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.67749585 |
| 12 | MP0001819_abnormal_immune_cell | 2.62859625 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.61071181 |
| 14 | MP0002723_abnormal_immune_serum | 2.55654619 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.50403902 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.49463571 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.49139085 |
| 18 | MP0002722_abnormal_immune_system | 2.48540369 |
| 19 | MP0000716_abnormal_immune_system | 2.47195200 |
| 20 | MP0008057_abnormal_DNA_replication | 2.46306968 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.43245393 |
| 22 | MP0010094_abnormal_chromosome_stability | 2.33454835 |
| 23 | MP0002405_respiratory_system_inflammati | 2.28848125 |
| 24 | MP0009785_altered_susceptibility_to | 2.26732602 |
| 25 | MP0003693_abnormal_embryo_hatching | 2.16384916 |
| 26 | MP0005025_abnormal_response_to | 2.13912671 |
| 27 | MP0002429_abnormal_blood_cell | 2.13186824 |
| 28 | MP0001873_stomach_inflammation | 2.12035812 |
| 29 | MP0002006_tumorigenesis | 2.06091069 |
| 30 | MP0003077_abnormal_cell_cycle | 2.04839435 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.02718651 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 1.99620499 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.96076177 |
| 34 | MP0003111_abnormal_nucleus_morphology | 1.88639873 |
| 35 | MP0006082_CNS_inflammation | 1.88025602 |
| 36 | MP0003436_decreased_susceptibility_to | 1.86292796 |
| 37 | MP0003866_abnormal_defecation | 1.83052256 |
| 38 | MP0004947_skin_inflammation | 1.71090139 |
| 39 | MP0000490_abnormal_crypts_of | 1.70195098 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.65760868 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.55431841 |
| 42 | MP0008058_abnormal_DNA_repair | 1.54567872 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.53407868 |
| 44 | MP0002019_abnormal_tumor_incidence | 1.52482227 |
| 45 | MP0002933_joint_inflammation | 1.49263519 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.48802325 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.48802325 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.47279335 |
| 49 | MP0001853_heart_inflammation | 1.44718109 |
| 50 | MP0002419_abnormal_innate_immunity | 1.44183308 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.43633708 |
| 52 | MP0000858_altered_metastatic_potential | 1.43590625 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.40018446 |
| 54 | MP0009278_abnormal_bone_marrow | 1.37753093 |
| 55 | MP0002132_abnormal_respiratory_system | 1.36708034 |
| 56 | MP0003303_peritoneal_inflammation | 1.31155626 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.29820596 |
| 58 | MP0003724_increased_susceptibility_to | 1.21758325 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.21733741 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.18340007 |
| 61 | MP0005310_abnormal_salivary_gland | 1.16558039 |
| 62 | MP0000350_abnormal_cell_proliferation | 1.14672379 |
| 63 | MP0001730_embryonic_growth_arrest | 1.04213543 |
| 64 | MP0009764_decreased_sensitivity_to | 1.03840317 |
| 65 | MP0003448_altered_tumor_morphology | 1.02230987 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.01335992 |
| 67 | MP0000313_abnormal_cell_death | 0.97801743 |
| 68 | MP0003045_fibrosis | 0.96768629 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.96566975 |
| 70 | MP0004510_myositis | 0.94138344 |
| 71 | MP0005076_abnormal_cell_differentiation | 0.90563643 |
| 72 | MP0010307_abnormal_tumor_latency | 0.89111266 |
| 73 | MP0005023_abnormal_wound_healing | 0.88122960 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 0.86974668 |
| 75 | MP0004381_abnormal_hair_follicle | 0.86622439 |
| 76 | MP0002009_preneoplasia | 0.86205042 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.84492323 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.83306384 |
| 79 | MP0008469_abnormal_protein_level | 0.81836200 |
| 80 | MP0003786_premature_aging | 0.81761728 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.78945094 |
| 82 | MP0000477_abnormal_intestine_morphology | 0.77574071 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 0.77121836 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.76237045 |
| 85 | MP0001663_abnormal_digestive_system | 0.75340505 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.74544244 |
| 87 | MP0002080_prenatal_lethality | 0.72415734 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.70664459 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.69534866 |
| 90 | MP0001697_abnormal_embryo_size | 0.67313643 |
| 91 | MP0001672_abnormal_embryogenesis/_devel | 0.66331498 |
| 92 | MP0005380_embryogenesis_phenotype | 0.66331498 |
| 93 | MP0005166_decreased_susceptibility_to | 0.65304641 |
| 94 | MP0003984_embryonic_growth_retardation | 0.64278422 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.63504207 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.62711067 |
| 97 | MP0001851_eye_inflammation | 0.60036158 |
| 98 | MP0002163_abnormal_gland_morphology | 0.59898229 |
| 99 | MP0004130_abnormal_muscle_cell | 0.58492847 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.58140610 |
| 101 | MP0004883_abnormal_blood_vessel | 0.57088120 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.56613170 |
| 103 | MP0003252_abnormal_bile_duct | 0.56310712 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.56142544 |
| 105 | MP0009763_increased_sensitivity_to | 0.55492575 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.54026222 |
| 107 | MP0005390_skeleton_phenotype | 0.53902645 |
| 108 | MP0003828_pulmonary_edema | 0.52275707 |
| 109 | MP0008932_abnormal_embryonic_tissue | 0.51978324 |
| 110 | MP0001919_abnormal_reproductive_system | 0.51417571 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.50506645 |
| 112 | MP0000249_abnormal_blood_vessel | 0.50363837 |
| 113 | MP0008260_abnormal_autophagy | 0.50308244 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.50037122 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.49747425 |
| 116 | MP0003795_abnormal_bone_structure | 0.49661651 |
| 117 | MP0005621_abnormal_cell_physiology | 0.49640005 |
| 118 | MP0003787_abnormal_imprinting | 0.49157523 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.48728869 |
| 120 | MP0000371_diluted_coat_color | 0.48353199 |
| 121 | MP0008770_decreased_survivor_rate | 0.47795478 |
| 122 | MP0002085_abnormal_embryonic_tissue | 0.46589178 |
| 123 | MP0002084_abnormal_developmental_patter | 0.45164472 |
| 124 | MP0008873_increased_physiological_sensi | 0.44897770 |
| 125 | MP0002083_premature_death | 0.43718300 |
| 126 | MP0002928_abnormal_bile_duct | 0.42840948 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.41595140 |
| 128 | MP0008874_decreased_physiological_sensi | 0.39686493 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.38717176 |
| 130 | MP0000609_abnormal_liver_physiology | 0.37580805 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.35312810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.51639614 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.20585504 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 5.12975822 |
| 4 | Combined immunodeficiency (HP:0005387) | 5.07035367 |
| 5 | Abnormality of T cells (HP:0002843) | 4.95009231 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.88380357 |
| 7 | IgM deficiency (HP:0002850) | 4.87516565 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.86895617 |
| 9 | Recurrent viral infections (HP:0004429) | 4.45385691 |
| 10 | B lymphocytopenia (HP:0010976) | 4.29897165 |
| 11 | Abnormality of B cell number (HP:0010975) | 4.29897165 |
| 12 | IgG deficiency (HP:0004315) | 4.23127796 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.17876652 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.02596975 |
| 15 | Thyroiditis (HP:0100646) | 3.98542897 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96746029 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.88376095 |
| 18 | Chronic otitis media (HP:0000389) | 3.84910035 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.79243712 |
| 20 | Orchitis (HP:0100796) | 3.76320786 |
| 21 | Nasal polyposis (HP:0100582) | 3.75268845 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73491781 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.53704862 |
| 24 | Lymphopenia (HP:0001888) | 3.48191470 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.46408894 |
| 26 | Basal cell carcinoma (HP:0002671) | 3.43705820 |
| 27 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.42341373 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.41067153 |
| 29 | Pustule (HP:0200039) | 3.37131745 |
| 30 | Abnormality of eosinophils (HP:0001879) | 3.35238988 |
| 31 | Eosinophilia (HP:0001880) | 3.23244008 |
| 32 | Meningitis (HP:0001287) | 3.21707111 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19871241 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19871241 |
| 35 | Lymphoma (HP:0002665) | 3.15693165 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.14334090 |
| 37 | Stomatitis (HP:0010280) | 3.14171377 |
| 38 | Myositis (HP:0100614) | 3.04904830 |
| 39 | Hypoplasia of the thymus (HP:0000778) | 3.04347509 |
| 40 | Granulocytopenia (HP:0001913) | 3.00432040 |
| 41 | Papilloma (HP:0012740) | 2.96609227 |
| 42 | Verrucae (HP:0200043) | 2.96609227 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93631629 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.93156937 |
| 45 | IgA deficiency (HP:0002720) | 2.90008977 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.86269737 |
| 47 | Leukocytosis (HP:0001974) | 2.83267703 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.81822887 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.79021820 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.78401760 |
| 51 | Bronchitis (HP:0012387) | 2.75409063 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.74045218 |
| 53 | Increased IgM level (HP:0003496) | 2.71652031 |
| 54 | Chronic diarrhea (HP:0002028) | 2.71504981 |
| 55 | Thrombocytosis (HP:0001894) | 2.70402698 |
| 56 | Keratoconjunctivitis (HP:0001096) | 2.68601774 |
| 57 | Reticulocytopenia (HP:0001896) | 2.64886501 |
| 58 | Urticaria (HP:0001025) | 2.52245289 |
| 59 | Cellulitis (HP:0100658) | 2.49590240 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.49557864 |
| 61 | Encephalitis (HP:0002383) | 2.49492097 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.48899289 |
| 63 | Vasculitis (HP:0002633) | 2.46466732 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.44698371 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.37741876 |
| 66 | Abnormal number of erythroid precursors (HP:0012131) | 2.36952952 |
| 67 | Gastrointestinal stroma tumor (HP:0100723) | 2.36398630 |
| 68 | Chronic sinusitis (HP:0011109) | 2.33755089 |
| 69 | Poikiloderma (HP:0001029) | 2.32696474 |
| 70 | Amaurosis fugax (HP:0100576) | 2.31491808 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.28080660 |
| 72 | Recurrent otitis media (HP:0000403) | 2.28051969 |
| 73 | Colitis (HP:0002583) | 2.25516849 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.25467116 |
| 75 | Pulmonary embolism (HP:0002204) | 2.24811207 |
| 76 | Increased IgE level (HP:0003212) | 2.22348779 |
| 77 | Acute hepatic failure (HP:0006554) | 2.22068856 |
| 78 | Joint swelling (HP:0001386) | 2.21590866 |
| 79 | Papilledema (HP:0001085) | 2.17423908 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.17366411 |
| 81 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.15929976 |
| 82 | Gingivitis (HP:0000230) | 2.14521266 |
| 83 | Stomach cancer (HP:0012126) | 2.09698198 |
| 84 | Skin rash (HP:0000988) | 2.08938486 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.08343891 |
| 86 | Arterial thrombosis (HP:0004420) | 2.06089028 |
| 87 | Obstructive lung disease (HP:0006536) | 2.04471313 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04471313 |
| 89 | Gangrene (HP:0100758) | 2.04358753 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.03619655 |
| 91 | Anorexia (HP:0002039) | 2.02210359 |
| 92 | Emphysema (HP:0002097) | 2.01267213 |
| 93 | Osteomyelitis (HP:0002754) | 1.98258560 |
| 94 | Recurrent skin infections (HP:0001581) | 1.97739955 |
| 95 | Myelodysplasia (HP:0002863) | 1.96594585 |
| 96 | Hypochromic anemia (HP:0001931) | 1.94850637 |
| 97 | Ependymoma (HP:0002888) | 1.92689529 |
| 98 | Hypoproteinemia (HP:0003075) | 1.91262422 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 1.91120668 |
| 100 | Gingival bleeding (HP:0000225) | 1.88854108 |
| 101 | Recurrent pneumonia (HP:0006532) | 1.88748514 |
| 102 | Prominent nose (HP:0000448) | 1.88456307 |
| 103 | Petechiae (HP:0000967) | 1.86500732 |
| 104 | Birth length less than 3rd percentile (HP:0003561) | 1.86245841 |
| 105 | Hemoptysis (HP:0002105) | 1.83844264 |
| 106 | Cellular immunodeficiency (HP:0005374) | 1.83802010 |
| 107 | Abnormal platelet volume (HP:0011876) | 1.82987139 |
| 108 | Leukopenia (HP:0001882) | 1.82722248 |
| 109 | Skin ulcer (HP:0200042) | 1.81030625 |
| 110 | Retrobulbar optic neuritis (HP:0100654) | 1.80563945 |
| 111 | Optic neuritis (HP:0100653) | 1.80563945 |
| 112 | Epistaxis (HP:0000421) | 1.78740560 |
| 113 | Pulmonary infiltrates (HP:0002113) | 1.77556759 |
| 114 | Volvulus (HP:0002580) | 1.76792125 |
| 115 | Chest pain (HP:0100749) | 1.76616816 |
| 116 | Pallor (HP:0000980) | 1.74688653 |
| 117 | Aplastic anemia (HP:0001915) | 1.74134236 |
| 118 | Medulloblastoma (HP:0002885) | 1.72704080 |
| 119 | Sepsis (HP:0100806) | 1.72595284 |
| 120 | Abnormality of DNA repair (HP:0003254) | 1.71864268 |
| 121 | Absent thumb (HP:0009777) | 1.71617411 |
| 122 | Squamous cell carcinoma (HP:0002860) | 1.70245911 |
| 123 | Microcytic anemia (HP:0001935) | 1.70071632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.84212201 |
| 2 | TXK | 4.42862207 |
| 3 | TAOK3 | 3.04904028 |
| 4 | RIPK4 | 2.90839019 |
| 5 | GRK6 | 2.86209122 |
| 6 | ZAP70 | 2.83699457 |
| 7 | EEF2K | 2.81165454 |
| 8 | STK10 | 2.71763089 |
| 9 | MAP3K10 | 2.48348866 |
| 10 | ITK | 2.45879043 |
| 11 | JAK3 | 2.37113241 |
| 12 | CDK12 | 2.06211878 |
| 13 | TESK2 | 1.96178244 |
| 14 | TYK2 | 1.87235676 |
| 15 | PRPF4B | 1.83417449 |
| 16 | FGFR4 | 1.82979434 |
| 17 | BTK | 1.77007158 |
| 18 | SYK | 1.74559979 |
| 19 | LCK | 1.70681860 |
| 20 | IKBKE | 1.61525820 |
| 21 | KDR | 1.57567355 |
| 22 | NME2 | 1.57061409 |
| 23 | CDC7 | 1.51038317 |
| 24 | CSK | 1.48396882 |
| 25 | TEC | 1.47937138 |
| 26 | RPS6KB2 | 1.46600703 |
| 27 | NLK | 1.46052240 |
| 28 | MST4 | 1.44185608 |
| 29 | BLK | 1.43164659 |
| 30 | LRRK2 | 1.40890125 |
| 31 | PIM1 | 1.34880199 |
| 32 | CSF1R | 1.34483295 |
| 33 | NEK2 | 1.32471556 |
| 34 | JAK1 | 1.28670900 |
| 35 | FGFR3 | 1.28513474 |
| 36 | PKN2 | 1.23239221 |
| 37 | HCK | 1.22332879 |
| 38 | CLK1 | 1.19755264 |
| 39 | FLT3 | 1.18976711 |
| 40 | MAP3K11 | 1.18573641 |
| 41 | MAP3K14 | 1.14618301 |
| 42 | KIT | 1.14265607 |
| 43 | CDK4 | 1.13453047 |
| 44 | BUB1 | 1.04125344 |
| 45 | PASK | 1.03962458 |
| 46 | TBK1 | 1.03180255 |
| 47 | TNK2 | 1.02240065 |
| 48 | RPS6KA4 | 1.00751957 |
| 49 | SIK2 | 1.00089160 |
| 50 | STK4 | 1.00007981 |
| 51 | LYN | 0.94991713 |
| 52 | IKBKB | 0.93546489 |
| 53 | BRD4 | 0.93287707 |
| 54 | CAMKK2 | 0.91822788 |
| 55 | MAP2K2 | 0.91082368 |
| 56 | MARK3 | 0.89801260 |
| 57 | TLK1 | 0.85288766 |
| 58 | PRKCQ | 0.84652159 |
| 59 | ALK | 0.81579484 |
| 60 | ATR | 0.81453040 |
| 61 | CAMKK1 | 0.79169379 |
| 62 | WEE1 | 0.76413786 |
| 63 | BMPR2 | 0.75001998 |
| 64 | TGFBR1 | 0.72522618 |
| 65 | BCKDK | 0.72252241 |
| 66 | MAP3K13 | 0.71446388 |
| 67 | PRKCH | 0.70942027 |
| 68 | MAPKAPK3 | 0.70741916 |
| 69 | GRK7 | 0.69748619 |
| 70 | MAP3K8 | 0.69547781 |
| 71 | IRAK4 | 0.66593749 |
| 72 | CDK7 | 0.66015335 |
| 73 | MAP3K7 | 0.65582211 |
| 74 | TSSK6 | 0.63299205 |
| 75 | FYN | 0.62300210 |
| 76 | FGR | 0.62038355 |
| 77 | ACVR1B | 0.61954283 |
| 78 | MAP2K3 | 0.60983724 |
| 79 | FES | 0.60756712 |
| 80 | MAPK12 | 0.58981952 |
| 81 | EIF2AK1 | 0.57662688 |
| 82 | MELK | 0.57498534 |
| 83 | MAPK11 | 0.57038047 |
| 84 | CHEK1 | 0.56255358 |
| 85 | ERN1 | 0.55335383 |
| 86 | CHUK | 0.54985193 |
| 87 | SIK3 | 0.54712957 |
| 88 | HIPK2 | 0.54388963 |
| 89 | MAP2K6 | 0.52573554 |
| 90 | SRPK1 | 0.51553348 |
| 91 | SMG1 | 0.51041697 |
| 92 | JAK2 | 0.50600415 |
| 93 | PIK3CG | 0.49116908 |
| 94 | TRIB3 | 0.48845912 |
| 95 | ADRBK2 | 0.48750602 |
| 96 | CDK6 | 0.46409198 |
| 97 | TAOK1 | 0.46039193 |
| 98 | TGFBR2 | 0.45860609 |
| 99 | EIF2AK3 | 0.45756912 |
| 100 | DYRK3 | 0.45051427 |
| 101 | CDK9 | 0.43236354 |
| 102 | MAP3K1 | 0.42845124 |
| 103 | TYRO3 | 0.42839318 |
| 104 | CDK2 | 0.38769014 |
| 105 | CDC42BPA | 0.38729856 |
| 106 | PLK1 | 0.37500943 |
| 107 | MAPK7 | 0.37319642 |
| 108 | PRKD2 | 0.37075649 |
| 109 | MAPKAPK2 | 0.36595138 |
| 110 | TESK1 | 0.36231903 |
| 111 | MARK2 | 0.36126072 |
| 112 | * AURKB | 0.35662947 |
| 113 | ATM | 0.35270214 |
| 114 | VRK1 | 0.35100580 |
| 115 | PDGFRB | 0.34884293 |
| 116 | NUAK1 | 0.34662789 |
| 117 | INSR | 0.34498186 |
| 118 | EPHA3 | 0.33373079 |
| 119 | MAP3K3 | 0.32341506 |
| 120 | RPS6KA5 | 0.31739185 |
| 121 | MAPK3 | 0.29891168 |
| 122 | IRAK1 | 0.29109941 |
| 123 | RPS6KA6 | 0.28288062 |
| 124 | MAPK4 | 0.27546793 |
| 125 | EPHB1 | 0.27506202 |
| 126 | PDK1 | 0.27471425 |
| 127 | RPS6KC1 | 0.25263485 |
| 128 | RPS6KL1 | 0.25263485 |
| 129 | MATK | 0.24839796 |
| 130 | STK11 | 0.24407909 |
| 131 | GRK5 | 0.23276139 |
| 132 | TAOK2 | 0.22660526 |
| 133 | ABL1 | 0.22316282 |
| 134 | PTK6 | 0.22275946 |
| 135 | IGF1R | 0.19366983 |
| 136 | PRKD1 | 0.18876629 |
| 137 | PDPK1 | 0.17643971 |
| 138 | PRKCD | 0.17140308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.55072870 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.98064579 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.90464446 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.69750372 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.65385510 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.46776571 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40223030 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34330479 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.19491964 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.18905515 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.15405021 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09508944 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07592087 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05729163 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.05273147 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04199094 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80624714 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.76644818 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74436663 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.71404929 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.62078888 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60083674 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.54187295 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.47225173 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44515324 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38260239 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37452676 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.33773347 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33575551 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28879232 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28772277 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28735766 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25496143 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22207331 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.21766766 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21086863 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18968928 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18309676 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17746822 |
| 40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.17476102 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16763794 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15444988 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15284970 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.13999795 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.10454084 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07648843 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.07508672 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06062750 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.03660294 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00876264 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.97111936 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.95415570 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90965988 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90420086 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89587373 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88595637 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.84355444 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82718728 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79793508 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78427946 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75608092 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75499419 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75043105 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69620169 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68532091 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.68276878 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67664320 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.67074451 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61064700 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61047515 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.60582093 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60014160 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59943785 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.59499851 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58348410 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57948041 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57683594 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55574367 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52726835 |
| 80 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50532315 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.45992039 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.45988438 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.44638582 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44425046 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43941373 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.43933931 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43526745 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43296421 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42308447 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42114617 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41843782 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41578097 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.40214680 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39634647 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36683928 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36306194 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35478791 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34375184 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34226162 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33755753 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32673782 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31540458 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31099110 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30089497 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29919097 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29844498 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29629236 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29600234 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29580329 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28741620 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.28163237 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.27435854 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26957413 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25920700 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.25531855 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25319108 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25264400 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24331031 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24293405 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22197421 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.19342349 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18175195 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18104559 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17241588 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16047725 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14874558 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13797633 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.11577821 |
| 129 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08402340 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08360447 |
| 131 | Phototransduction_Homo sapiens_hsa04744 | 0.06476424 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06308128 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04847322 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.04277622 |

